Search research articles
Contact Us
Filters
Showing results (131-140 of 575) with videos related to
Page
of 58
Sort By:
The Oncologist
|
August 7, 2013
Second-Line Therapy for Advanced NSCLC
Jared M Weiss, Thomas E Stinchcombe
Proceedings. Biological Sciences
|
October 31, 2014
Standing genetic variation in host preference for mutualist microbial symbionts
Anna K Simonsen, John R Stinchcombe
The Lancet. Oncology
|
May 25, 2010
Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?
Thomas E Stinchcombe, Suresh S Ramalingam
Molecular Ecology
|
November 17, 2017
A window into the transcriptomic basis of genotype-by-genotype interactions in the legume-rhizobia mutualism
Corlett W Wood, John R Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2022
Thoracic Oncology: Current Standard Therapy and Future Developments
Thomas E Stinchcombe, Jeffrey D Bradley
The Oncologist
|
September 12, 2008
Gefitinib in advanced non-small cell lung cancer: does it deserve a second chance?
Thomas E Stinchcombe, Mark A Socinski
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 31, 2009
Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of therapy
Thomas E Stinchcombe, Mark A Socinski
Proceedings. Biological Sciences
|
January 9, 2009
How much do genetic covariances alter the rate of adaptation?
Aneil F Agrawal, John R Stinchcombe
Molecular Ecology
|
August 21, 2016
Multiple mutualist effects on genomewide expression in the tripartite association between Medicago truncatula, nitrogen-fixing bacteria and mycorrhizal fungi
Michelle E Afkhami, John R Stinchcombe
Seminars in Cell Biology
|
October 1, 1992
Biogenesis of secretory granules
S A Tooze, J C Stinchcombe
Page
of 58
Search research articles
Search
Showing results (131-140 of 575) with videos related to
Sort By:
Page
of 58
The Oncologist
|
August 7, 2013
Second-Line Therapy for Advanced NSCLC
Jared M Weiss, Thomas E Stinchcombe
Proceedings. Biological Sciences
|
October 31, 2014
Standing genetic variation in host preference for mutualist microbial symbionts
Anna K Simonsen, John R Stinchcombe
The Lancet. Oncology
|
May 25, 2010
Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?
Thomas E Stinchcombe, Suresh S Ramalingam
Molecular Ecology
|
November 17, 2017
A window into the transcriptomic basis of genotype-by-genotype interactions in the legume-rhizobia mutualism
Corlett W Wood, John R Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2022
Thoracic Oncology: Current Standard Therapy and Future Developments
Thomas E Stinchcombe, Jeffrey D Bradley
The Oncologist
|
September 12, 2008
Gefitinib in advanced non-small cell lung cancer: does it deserve a second chance?
Thomas E Stinchcombe, Mark A Socinski
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 31, 2009
Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of therapy
Thomas E Stinchcombe, Mark A Socinski
Proceedings. Biological Sciences
|
January 9, 2009
How much do genetic covariances alter the rate of adaptation?
Aneil F Agrawal, John R Stinchcombe
Molecular Ecology
|
August 21, 2016
Multiple mutualist effects on genomewide expression in the tripartite association between Medicago truncatula, nitrogen-fixing bacteria and mycorrhizal fungi
Michelle E Afkhami, John R Stinchcombe
Seminars in Cell Biology
|
October 1, 1992
Biogenesis of secretory granules
S A Tooze, J C Stinchcombe
Page
of 58